TP53 and cancer: In addition, TP53 deficiency produces radio resistance in cancer cells and tumors through SLC7A11-mediated ferroptosis inhibition, thus suggesting that sulfasalazine in combination with irradiation may be beneficial in TP53-mutant NSCLC15.